AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Oncopeptides

Major Shareholding Notification Aug 3, 2020

3091_iss_2020-08-03_97399774-0e7d-4220-bdae-6d1fc8826f20.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Oncopeptides AB

Holder

Fjärde AP-fonden

Instrument

Instrument Aktier
Before the transaction
Shares 3,200,000
Voting rights 3,200,000
Transaction
Reason for major shareholding notification Corporate action
Date 31/07/2020
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 3,200,000
Directly held voting rights 3,200,000
Indirectly held voting rights 0
Percentage
Directly held shares 4.72 %
Directly held voting rights 4.72 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 4.72 % 3,200,000
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 4.72 % 3,200,000
Group
total
holdings
Voting rights
3,200,000
Percentage of voting rights 4.72
Published
03/08/2020 21:36
Contact
Name
Jannis Kitsakis
Phone
070-6038023 Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.